How much products actually contain
No product states its amount yet.
Of the products containing it, 1 list it before the 1% line and 0 after it (usually 1% or less).
Products using this ingredient
1 of 1 confirmed · likeliest to carry enough first
Definition
US FDA substance register · UNII 8O0C852CPO · registered name NATAMYCIN · single chemical substance
Cosmetic roles
Stops microbes growing in the productPRESERVATIVEInhibits microbial growthANTIMICROBIAL
More data — names, identifiers, properties, test records, literature
Names & identifiers
NATAMYCININCI
- CAS No.chemical registry number
- 7681-93-8
- EC No.EU chemical inventory number
- 231-683-5
- EC No.EU chemical inventory number
- 231-683-5 (I)
- DTXSIDUS EPA chemical ID
- DTXSID6021163
- DTXCIDUS EPA compound ID
- DTXCID301163
- IUPAC
- (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20- pentaene-25-carboxylic acid
- Molecular formula
- C33H47NO13
- Molecular weight
- 665.733 g/mol
Measured properties
- Appearance
- solid
- Melting/freezing point
- 280 ℃
- Initial boiling point and range
- 937.83 ℃
- Vapour pressure
- 1.13E-29 ㎜Hg (at 25°C)
- Water solubility
- 4100 ㎎/ℓ (at 21°C)
- Vapour density
- 22.98008284432171
- n-Octanol/water partition coefficient (Kow)
- (log P 1.1(Pubchem))
Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.
Source: KOSHA safety data sheets (Korea)
What products actually use it for
What the 5 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Biocide3
- Preservative2
Source: US EPA CompTox dashboard
Related literature
- Ethosomes - based natamycin delivery system: a potential approach for treating fungal infection · 2025
- Comparative Evaluation of Topical Monotherapy (Natamycin or Natasol) and Combination Therapy (Natamycin and Voriconazole) in Mild-Moderate Fungal Keratitis. · 2024
- Physiochemical Characterization of Lipidic Nanoformulations Encapsulating the Antifungal Drug Natamycin · 2024
- Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics · 2023
- Novel Water Soluble Sterile Natamycin Formulation (Natasol) for Fungal Keratitis. · 2021
Linked databases 12
- ChEBI
- ChEMBL
- EU CosIng ingredient list 2
- KOSHA safety data sheets (Korea)
- Tlooto literature search 2 3 4 5
- UniChem cross-reference IDs
- US EPA CompTox dashboard 2
- US EPA DSSTox chemical database
- US FDA substance registration (GSRS)
- US FDA Unique Ingredient Identifier (UNII)
- Wikidata
- Wikipedia · English · Japanese · Chinese